Annual CFO
-$65.75 M
-$14.57 M-28.48%
30 June 2022
Summary:
Applied Genetic Technologies annual cash flow from operations is currently -$65.75 million, with the most recent change of -$14.57 million (-28.48%) on 30 June 2022. During the last 3 years, it has fallen by -$14.57 million (-28.48%).AGTC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$16.04 M
+$2.22 M+12.16%
30 September 2022
Summary:
Applied Genetic Technologies quarterly cash flow from operations is currently -$16.04 million, with the most recent change of +$2.22 million (+12.16%) on 30 September 2022.AGTC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$65.85 M
-$101.00 K-0.15%
30 September 2022
Summary:
Applied Genetic Technologies TTM cash flow from operations is currently -$65.85 million, with the most recent change of -$101.00 thousand (-0.15%) on 30 September 2022.AGTC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGTC Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -28.5% | -0.6% | -21.5% |
| 5 y5 years | -180.3% | -49.7% | -89.5% |
AGTC Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -192.6% | -116.9% | -182.8% |
Applied Genetic Technologies Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$16.04 M(-12.2%) | -$65.85 M(+0.2%) |
| June 2022 | -$65.75 M(+28.5%) | -$18.26 M(+30.4%) | -$65.75 M(+7.9%) |
| Mar 2022 | - | -$14.00 M(-20.3%) | -$60.92 M(+4.4%) |
| Dec 2021 | - | -$17.56 M(+10.2%) | -$58.36 M(+7.7%) |
| Sept 2021 | - | -$15.94 M(+18.6%) | -$54.19 M(+5.9%) |
| June 2021 | -$51.17 M(+23.0%) | -$13.44 M(+17.5%) | -$51.17 M(-0.6%) |
| Mar 2021 | - | -$11.43 M(-14.6%) | -$51.50 M(+5.3%) |
| Dec 2020 | - | -$13.39 M(+3.7%) | -$48.89 M(+11.6%) |
| Sept 2020 | - | -$12.92 M(-6.2%) | -$43.82 M(+5.3%) |
| June 2020 | -$41.62 M(+77.4%) | -$13.77 M(+56.1%) | -$41.62 M(+17.6%) |
| Mar 2020 | - | -$8.82 M(+6.0%) | -$35.39 M(+5.6%) |
| Dec 2019 | - | -$8.32 M(-22.3%) | -$33.52 M(-3.6%) |
| Sept 2019 | - | -$10.71 M(+42.2%) | -$34.76 M(+48.2%) |
| June 2019 | -$23.46 M(-27.9%) | -$7.54 M(+8.5%) | -$23.46 M(+3.5%) |
| Mar 2019 | - | -$6.94 M(-27.4%) | -$22.66 M(-1.4%) |
| Dec 2018 | - | -$9.56 M(-1739.6%) | -$23.00 M(-1.2%) |
| Sept 2018 | - | $583.00 K(-108.6%) | -$23.29 M(-28.4%) |
| June 2018 | -$32.52 M(+4.9%) | -$6.74 M(-7.3%) | -$32.52 M(-9.1%) |
| Mar 2018 | - | -$7.28 M(-26.1%) | -$35.77 M(-2.6%) |
| Dec 2017 | - | -$9.85 M(+13.8%) | -$36.71 M(+8.4%) |
| Sept 2017 | - | -$8.65 M(-13.4%) | -$33.86 M(+9.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | -$31.00 M(-143.7%) | -$9.99 M(+21.6%) | -$31.00 M(+9.1%) |
| Mar 2017 | - | -$8.22 M(+17.5%) | -$28.41 M(+1.3%) |
| Dec 2016 | - | -$6.99 M(+20.7%) | -$28.04 M(-5.8%) |
| Sept 2016 | - | -$5.79 M(-21.7%) | -$29.76 M(-141.9%) |
| June 2016 | $70.99 M(-464.3%) | -$7.40 M(-5.8%) | $70.99 M(-1.4%) |
| Mar 2016 | - | -$7.85 M(-9.9%) | $71.98 M(-3.9%) |
| Dec 2015 | - | -$8.71 M(-109.2%) | $74.87 M(-5.8%) |
| Sept 2015 | - | $94.96 M(-1581.7%) | $79.52 M(-508.1%) |
| June 2015 | -$19.48 M(+63.4%) | -$6.41 M(+29.2%) | -$19.48 M(+22.0%) |
| Mar 2015 | - | -$4.96 M(+21.8%) | -$15.97 M(+9.3%) |
| Dec 2014 | - | -$4.07 M(+0.8%) | -$14.61 M(+4.2%) |
| Sept 2014 | - | -$4.04 M(+39.8%) | -$14.01 M(+17.5%) |
| June 2014 | -$11.93 M(+329.5%) | -$2.89 M(-19.7%) | -$11.93 M(+29.4%) |
| Mar 2014 | - | -$3.60 M(+3.5%) | -$9.22 M(+29.5%) |
| Dec 2013 | - | -$3.48 M(+77.8%) | -$7.12 M(+61.9%) |
| Sept 2013 | - | -$1.96 M(+993.3%) | -$4.40 M(+58.4%) |
| June 2013 | -$2.78 M(+102.4%) | -$179.00 K(-88.1%) | -$2.78 M(+6.9%) |
| Mar 2013 | - | -$1.50 M(+98.2%) | -$2.60 M(+137.5%) |
| Dec 2012 | - | -$759.00 K(+126.6%) | -$1.09 M(+226.6%) |
| Sept 2012 | - | -$335.00 K | -$335.00 K |
| June 2012 | -$1.37 M | - | - |
FAQ
- What is Applied Genetic Technologies annual cash flow from operations?
- What is the all time high annual CFO for Applied Genetic Technologies?
- What is Applied Genetic Technologies quarterly cash flow from operations?
- What is the all time high quarterly CFO for Applied Genetic Technologies?
- What is Applied Genetic Technologies TTM cash flow from operations?
- What is the all time high TTM CFO for Applied Genetic Technologies?
What is Applied Genetic Technologies annual cash flow from operations?
The current annual CFO of AGTC is -$65.75 M
What is the all time high annual CFO for Applied Genetic Technologies?
Applied Genetic Technologies all-time high annual cash flow from operations is $70.99 M
What is Applied Genetic Technologies quarterly cash flow from operations?
The current quarterly CFO of AGTC is -$16.04 M
What is the all time high quarterly CFO for Applied Genetic Technologies?
Applied Genetic Technologies all-time high quarterly cash flow from operations is $94.96 M
What is Applied Genetic Technologies TTM cash flow from operations?
The current TTM CFO of AGTC is -$65.85 M
What is the all time high TTM CFO for Applied Genetic Technologies?
Applied Genetic Technologies all-time high TTM cash flow from operations is $79.52 M